SCHEMBL8632106

SCHEMBL8632106

CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)C(OP(=O)(O)OCCN)[C@H](CO)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.52
SELP P16109 1/20 0.48
GPR55 Q9Y2T6 2/20 0.46
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
CNR1 P21554 2/20 0.45
THRB P10828 1/20 0.45
FAAH O00519 1/20 0.45
HPGD P15428 1/20 0.45
CNR2 P34972 1/20 0.45
DAGLA Q9Y4D2 1/20 0.43
P2RY10 O00398 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9951272 0.97 S1PR1 (0.54) S1PR1SELPGPR55ALDH1A1MAPT
SCHEMBL479264 0.97 S1PR1 (0.54) S1PR1SELPGPR55ALDH1A1MAPT
SCHEMBL9951800 0.96 S1PR1 (0.53) S1PR1SELPGPR55ALDH1A1MAPT
SCHEMBL19616499 0.96 S1PR1 (0.53) S1PR1SELPGPR55ALDH1A1MAPT
SCHEMBL9951988 0.95 S1PR1 (0.49) S1PR1SELPDAGLAP2RY10
SCHEMBL17595343 0.95 S1PR1 (0.49) S1PR1SELPDAGLAP2RY10
SCHEMBL2340054 0.95 S1PR1 (0.49) S1PR1SELPDAGLAP2RY10
SCHEMBL8627715 0.88 S1PR1 (0.46) S1PR1SELPGPR55ALDH1A1MAPT
SCHEMBL16964730 0.86 P2RY10 (0.43) S1PR1P2RY10
SCHEMBL9166758 0.86 PLA2G2C (0.43) MAPTDAGLAP2RY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0845981-A1 COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES GENZYME CORPORATION (US) 1998-06-10 EP disclosed
WO-1997046223-A1 COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES GENZYME CORPORATION (US) 1997-12-11 WO disclosed